PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2017.32.1.620173216The SCAP/SREBP Pathway: A Mediator of Hepatic SteatosisYoung-Ah Moonhttps://synapse.koreamed.org/pdf/10.3803/EnM.2017.32.1.6, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2017.32.1.6, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2017.32.1.6
Gastroenterology10.1016/s0016-5085(11)64081-x20111405S-984-S-985Guggulsterone Inhibits LXRα Mediated SREBP-1c-Dependent Hepatic Steatosis Through PKC Dependent PathwayEun Ju Cho, Jung-Hwan Yoonhttps://api.elsevier.com/content/article/PII:S001650851164081X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S001650851164081X?httpAccept=text/plain
Hong Kong Journal of Nephrology10.1016/j.hkjn.2015.08.0182015172S5Tangshen Formula Attenuates Hepatic Steatosis in db/db Mice by Mechanisms Involving AMPK/SREBP PathwayQin Kong, Ping Lihttps://api.elsevier.com/content/article/PII:S1561541315000496?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1561541315000496?httpAccept=text/plain
Science-Business eXchange10.1038/scibx.2009.131920092341319-1319Sterol regulatory element binding protein (SREBP); SREBP chaperone (SCAP)http://link.springer.com/content/pdf/10.1038/scibx.2009.1319.pdf, http://link.springer.com/article/10.1038/scibx.2009.1319/fulltext.html, http://link.springer.com/content/pdf/10.1038/scibx.2009.1319.pdf
Encyclopedia of Genetics, Genomics, Proteomics and Informatics10.1007/978-1-4020-6754-9_1509720081761-1761SCAP (SREBP cleavage-activating protein)http://link.springer.com/content/pdf/10.1007/978-1-4020-6754-9_15097
Scientific Reports10.1038/srep22640201661Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stabilityCaifeng Yan, Jinfeng Chen, Nuoqi Chenhttp://www.nature.com/articles/srep22640, http://www.nature.com/articles/srep22640.pdf, http://www.nature.com/articles/srep22640.pdf
Hepatology10.1053/jhep.2003.0902820033861529-1539Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppressionM Sekiyahttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjhep.2003.09028, https://onlinelibrary.wiley.com/doi/full/10.1053/jhep.2003.09028
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2010.01275.x20101283-92Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1cP. Ferré, F. Foufellehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1326.2010.01275.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01275.x/fullpdf
Journal of Hepatology10.1016/s0168-8278(11)61264-6201154S4981262 GUGGULSTERONE INHIBITS LXRα MEDIATED SREBP-1C-DEPENDENT HEPATIC STEATOSIS THROUGH PKC DEPENDENT PATHWAYE.J. Cho, E.S. Jang, M.S. Kwak, S.J. Yu, J.-H. Lee, J.-H. Yoonhttps://api.elsevier.com/content/article/PII:S0168827811612646?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827811612646?httpAccept=text/plain
Food & Function10.1039/c9fo00284g20191063410-3420Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathwayCong Zhang, Junjie Hu, Lei Sheng, Ming Yuan, Yong Wu, Liang Chen, Guihong Wang, Zhenpeng Qiuhttp://pubs.rsc.org/en/content/articlepdf/2019/FO/C9FO00284G